Water Street Healthcare Partners acquires Medical Specialties Distributors

Water Street Healthcare Partners, a leading private equity firm focused exclusively on health care, announced today that it has acquired Medical Specialties Distributors, LLC (MSD).  Headquartered in Stoughton, Massachusetts, MSD is the nation's leading provider of infusion products, supplies, biomedical services and technology solutions to the growing home infusion therapy market.  The acquisition expands Water Street's current group of health care companies to 12.

With U.S. demographics shifting toward an older population and an increasing number of people suffering from chronic conditions, the Centers for Medicare and Medicaid Services projects that home health care expenditures will reach more than $90 billion by 2014.  As demand for providing intravenous (IV) therapy to people in their homes continues to increase, MSD has grown to serve more than 4,000 customers.  The company supports a broad base of customers including specialty pharmacies and home infusion companies, such as Accredo Health Group, Inc., Coram Specialty Infusion Services and Walgreens Health Initiatives, Inc., as well as oncology clinics.

"MSD is uniquely positioned as the only national distributor that specializes in serving the needs of home infusion providers," said Rob Womsley, partner, Water Street Healthcare Partners.  "It has achieved steady growth by offering customers comprehensive solutions that support them with effectively managing and utilizing their products and supplies to ensure they meet their patients' day-to-day needs.  Our intention is to build on MSD's strong foundation and technology leadership to expand its services to the increasing number of providers who are enabling people to receive drug therapy services at home."

MSD offers customers a full range of infusion equipment and disposable supplies, as well as comprehensive services that encompass biomedical rental and repairs, equipment management and tracking, and formulary development.  The company employs more than 250 people, and operates eight fulfillment and service centers across the country.  Jim Beck, president and CEO of MSD, will continue to lead the company and its current management team.  He will work closely with Water Street's team, which includes former executives of global distribution businesses such as American Hospital Supply Corporation, Baxter International Inc. and McKesson Corporation.  

"Water Street is the ideal partner to help MSD advance our services and capabilities to provide greater value to our customers in this growing market," said Beck.  "I have known its partners for many years and believe they have an unmatched level of expertise building and operating specialty distribution businesses.  MSD will benefit tremendously from Water Street's expertise and ideas for how we can expand our services to the growing number of infusion centers and oncology clinics that are treating patients in the home."  

MSD marks Water Street's 25th transaction to build and create value in its portfolio of companies since its founding five years ago.  The firm's companies operate in a range of health care sectors including specialty distribution, medical devices and products, and specialty services.  MSD is Water Street's third investment in the medical distribution sector.  The firm also owns Sarnova, which has grown to become the leading national distributor to the respiratory and emergency medical services markets after Water Street acquired and merged Bound Tree Medical and Tri-anim Health Services, Inc. in 2008.

"Water Street is focused on building market-leading companies in attractive growth sectors of health care," said Jim Connelly, partner, Water Street Healthcare Partners. "Over the past five years, our team of health care leaders has creatively sourced opportunities and partnered with global leaders to methodically build a diverse group of companies with strong potential for expansion.  We will leverage our deep industry expertise and network of relationships to transform them into market leaders of significant value that are poised to achieve long-term sustainable growth."

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Baxter International Inc.. (2019, June 19). Water Street Healthcare Partners acquires Medical Specialties Distributors. News-Medical. Retrieved on May 06, 2024 from https://www.news-medical.net/news/20100731/Water-Street-Healthcare-Partners-acquires-Medical-Specialties-Distributors.aspx.

  • MLA

    Baxter International Inc.. "Water Street Healthcare Partners acquires Medical Specialties Distributors". News-Medical. 06 May 2024. <https://www.news-medical.net/news/20100731/Water-Street-Healthcare-Partners-acquires-Medical-Specialties-Distributors.aspx>.

  • Chicago

    Baxter International Inc.. "Water Street Healthcare Partners acquires Medical Specialties Distributors". News-Medical. https://www.news-medical.net/news/20100731/Water-Street-Healthcare-Partners-acquires-Medical-Specialties-Distributors.aspx. (accessed May 06, 2024).

  • Harvard

    Baxter International Inc.. 2019. Water Street Healthcare Partners acquires Medical Specialties Distributors. News-Medical, viewed 06 May 2024, https://www.news-medical.net/news/20100731/Water-Street-Healthcare-Partners-acquires-Medical-Specialties-Distributors.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Baxter reports topline results from BAX 111 Phase 3 trial for treatment of von Willebrand disease